In chronic refractory gout, where traditional xanthine oxidase inhibitors are not available, recombinant Uox has emerged as a promising treatment option, showing rapid reduction of hyperuricemia and dramatic tophi regression [33]. This evidence concerns the gene UOX and hyperuricemia.